Ionis Pharmaceuticals Inc (IONS)
38.58
-0.18
(-0.46%)
USD |
NASDAQ |
Nov 04, 13:16
Ionis Pharmaceuticals Price to Free Cash Flow
Price to Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Free Cash Flow Data
| Date | Value |
|---|---|
| December 30, 2022 | -- |
| December 29, 2022 | -- |
| December 28, 2022 | -- |
| December 27, 2022 | -- |
| December 23, 2022 | -- |
| December 22, 2022 | -- |
| December 21, 2022 | -- |
| December 20, 2022 | -- |
| December 19, 2022 | -- |
| December 16, 2022 | -- |
| December 15, 2022 | -- |
| December 14, 2022 | -- |
| December 13, 2022 | -- |
| December 12, 2022 | -- |
| December 09, 2022 | -- |
| December 08, 2022 | -- |
| December 07, 2022 | -- |
| December 06, 2022 | -- |
| December 05, 2022 | -- |
| December 02, 2022 | -- |
| December 01, 2022 | -- |
| November 30, 2022 | -- |
| November 29, 2022 | -- |
| November 28, 2022 | -- |
| November 25, 2022 | -- |
| Date | Value |
|---|---|
| November 23, 2022 | -- |
| November 22, 2022 | -- |
| November 21, 2022 | -- |
| November 18, 2022 | -- |
| November 17, 2022 | -- |
| November 16, 2022 | -- |
| November 15, 2022 | -- |
| November 14, 2022 | -- |
| November 11, 2022 | -- |
| November 10, 2022 | -- |
| November 09, 2022 | -- |
| November 08, 2022 | -- |
| November 07, 2022 | -- |
| November 04, 2022 | -- |
| November 03, 2022 | -- |
| November 02, 2022 | -- |
| November 01, 2022 | -- |
| October 31, 2022 | -- |
| October 28, 2022 | -- |
| October 27, 2022 | -- |
| October 26, 2022 | -- |
| October 25, 2022 | -- |
| October 24, 2022 | -- |
| October 21, 2022 | -- |
| October 20, 2022 | -- |
Price to Cash Flow Definition
Price to free cash flow measures the Price / TTM Free Cash Flow. Like other price ratios (ie. PE Ratio, PS Ratio, P/B Ratio), this metric can be used to compare companies with similar capital structures. Free cash flow gives an idea of how much cash is available for shareholders through stock buybacks and dividend payouts. A lower price to free cash flow is more desirable when assessing different companies.